OpenAlex
PricingAboutJobs
Log inGet started
Work

Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4

HTML

Year: 2004
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: American Journal of Kidney Diseases
DOI: 10.1053/j.ajkd.2004.01.012
Authors: Jack W Coburn, Hla M Maung, Logan Elangovan, Michael J Germain, Jill S Lindberg, Stuart M Sprague, Mark E Williams, Charles W Bishop
Institutions: University of California, Los Angeles, VA West Los Angeles Medical Center, Ochsner Medical Center, Joslin Diabetes Center, Diabetes & Glandular Disease Clinic
Language: English

Topic: Parathyroid Disorders and Treatments
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: doxercalciferol, secondary hyperparathyroidism, chronic kidney disease stage 3-4, parathyroid hormone suppression, 1,25-dihydroxyvitamin D3, vitamin D analogs, hypercalcemia, hyperphosphatemia, hypercalciuria, bone turnover markers, glomerular filtration rate, drug safety
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1993858578
FWCI: 11.02
Cites: 47
Cited by: 175
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms